Nathan R. Foster

Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer

Daniel J. Sargent, Silvia Marsoni, Geneviève Monges et al. · Journal of Clinical Oncology · 2010 · 1.6K citations · Full text

DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy

Frank A. Sinicrope, Nathan R. Foster, Stephen N. Thibodeau et al. · JNCI Journal of the National Cancer Institute · 2011 · 522 citations

A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma

M.B. Farnell, Randall K. Pearson, Michael G. Sarr et al. · Surgery · 2005 · 481 citations

Extended Lymphadenectomy, Surgical Oncology, Pancreatic Cancer +4

Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)

Wan‐Teck Lim, Boon Cher Goh, Edwin P. Hui et al. · Journal of Clinical Oncology · 2018 · 455 citations · Full text

Metastatic Npc, Oncology, Antitumor Activity +15

Intraepithelial Effector (CD3+)/Regulatory (FoxP3+) T-Cell Ratio Predicts a Clinical Outcome of Human Colon Carcinoma

Frank A. Sinicrope, Rafaela L. Rego, Stephen M. Ansell et al. · Gastroenterology · 2009 · 320 citations · Full text

Tumor Biology, T-cell Ratio, Human Colon Carcinoma +9